October 5, 2020

CLEAR adds LabCorp COVID-19 test results to “Health Pass” mobile app

NEW YORK & BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 5, 2020-- CLEAR, the secure identity company, and LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, today announced a partnership to enable users of CLEAR’s Health Pass mobile app to securely link their LabCorp test results using their LabCorp Patient™ account. The partnership brings together LabCorp’s advanced testing capabilities, including its COVID-19 tests, with CLEAR’s safe and secure Health Pass technology.
October 2, 2020

LabCorp COVID-19 molecular test innovation receives FDA authorization

BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 2, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, today announced that it is the first commercial laboratory to receive an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for a new, high-throughput method that uses heat and technology to extract RNA from samples collected for COVID-19 molecular testing. The advancement will help the company improve the speed and efficiency of RT-PCR tests, considered the ‘gold standard’ for active infections.1

Labcorp and GENFIT Sign Exclusive Agreement to Commercialize a Novel Diagnostic Test for Liver Disease

Labcorp to Announce Third Quarter Financial Results on October 27, 2020